QuiaPEG Pharmaceuticals operates in medical technology. The company has developed a technological platform that is used to improve and develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.

Quotes for QuiaPEG Pharmaceuticals Holding AB

+/-
%
()

Board

CEO

  • Marcus Bosson

Chairperson of the Board

  • Steen Krøyer

Board

  • Johan von Kantzow
  • Lars Linzander
  • Marcus Bosson
  • Marek Kwiatkowski
  • Mats Nilsson
  • Articles of association

    • News

    Show More

    Analysis

    Videos

    QuiaPEG väljer peg-liraglutid som första läkemedelsprojekt

    QuiaPEG Pharmaceuticals Sitdown mars 2018

    Quiapeg förbättrar beprövade läkemedel med PEGylering

    Annual reports, prospectus etc.